Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Atsuo Tahara
SGLT2 Inhibitor Ipragliflozin Alone and Combined With Pioglitazone Prevents Progression of Nonalcoholic Steatohepatitis in a Type 2 Diabetes Rodent Model
Physiological Reports
Physiology
In Vitro Pharmacological Profile of Ipragliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science
Related publications
DPP-4/SGLT2 Inhibitor Combined Therapy for Type 2 Diabetes
Prescriber
Pharmacology
The Xanthine Oxidase Inhibitor Febuxostat Suppresses Development of Nonalcoholic Steatohepatitis in a Rodent Model
American Journal of Physiology - Gastrointestinal and Liver Physiology
Hepatology
Physiology
Gastroenterology
Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
Peroxiredoxin 4 Protects Against Nonalcoholic Steatohepatitis and Type 2 Diabetes in a Nongenetic Mouse Model
Antioxidants and Redox Signaling
Cell Biology
Molecular Biology
Biochemistry
Clinical Biochemistry
Medicine
Physiology
Ertugliflozin: A New SGLT2 Inhibitor for Type 2 Diabetes
Prescriber
Pharmacology
Sitagliptin Delays Progression of Renal Lesions in a Rodent Model of Type 2 Diabetes
Journal of Comparative Pathology
Forensic Medicine
Pathology
Veterinary
Effective SGLT2 Inhibitor for Patient With Type 2 Diabetes Mellitus (T2DM) and Depression
Qtern: DPP-4 and SGLT2 Inhibitor Combination for Type 2 Diabetes
Prescriber
Pharmacology
Effects of Dapagliflozin, an SGLT2 Inhibitor, on HbA1c, Body Weight, and Hypoglycemia Risk in Patients With Type 2 Diabetes Inadequately Controlled on Pioglitazone Monotherapy
Diabetes Care
Internal Medicine
Endocrinology
Advanced
Metabolism
Specialized Nursing
Diabetes
